Labopharm Inc. (NASDAQ: DDSS) today announced that it has priced an underwritten public offering of 11,764,706 newly issued units at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE